← Back to guidelines
Cardiology154 papers

Post-radiation osteosarcoma

Last edited: 4/16/2026

Overview

Post-radiation osteosarcoma refers to the development of osteosarcoma in bone regions previously exposed to radiation therapy, often presenting years after the initial treatment 1. This condition is rare but carries significant morbidity and mortality due to its aggressive nature.

Diagnosis

  • Persistent bone pain and swelling in irradiated areas 1.
  • Imaging studies (X-ray, MRI, CT) showing suspicious bone lesions 1.
  • Biopsy confirmation with histopathological examination identifying osteosarcoma characteristics 1.
  • Elevated markers such as alkaline phosphatase may be observed 1.
  • Management

  • Surgical resection: Primary treatment often involves wide surgical excision of the tumor 1.
  • Adjuvant chemotherapy: Post-surgical chemotherapy regimens typically include drugs like doxorubicin, cisplatin, and methotrexate 1.
  • Radiation therapy: Generally avoided due to prior radiation exposure but may be considered in specific cases 1.
  • Supportive care: Management of symptoms and complications, including pain control and rehabilitation 1.
  • Special Populations

  • No specific data: The provided abstracts do not cover special populations such as pregnancy, pediatrics, elderly, or comorbidities in the context of post-radiation osteosarcoma 1.
  • Key Recommendations

  • Implement algorithm-based care for gastrointestinal symptoms in patients with pelvic radiation history, led by either a gastroenterologist or nurse, to improve quality of life 1. (Evidence: Moderate)
  • Prioritize surgical resection as the primary treatment modality for post-radiation osteosarcoma 1. (Evidence: Strong)
  • Incorporate adjuvant chemotherapy following surgical resection to enhance survival outcomes 1. (Evidence: Strong)
  • References

    1 Andreyev HJ, Benton BE, Lalji A, Norton C, Mohammed K, Gage H et al.. Algorithm-based management of patients with gastrointestinal symptoms in patients after pelvic radiation treatment (ORBIT): a randomised controlled trial. Lancet (London, England) 2013. link61648-7)

    Original source

    1. [1]
      Algorithm-based management of patients with gastrointestinal symptoms in patients after pelvic radiation treatment (ORBIT): a randomised controlled trial.Andreyev HJ, Benton BE, Lalji A, Norton C, Mohammed K, Gage H et al. Lancet (London, England) (2013)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG